Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-26-027205
Filing Date
2026-04-24
Accepted
2026-04-24 16:09:04
Documents
21
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A jazz-20251231.htm   iXBRL 10-K/A 1448350
2 EX-31.3 jazz10-kafy2025exhibit313.htm EX-31.3 5467
3 EX-31.4 jazz10-kafy2025exhibit314.htm EX-31.4 5493
7 jazz-20251231_g1.jpg GRAPHIC 18757
8 jazz-20251231_g2.jpg GRAPHIC 18559
9 jazz-20251231_g3.jpg GRAPHIC 18114
10 jazz-20251231_g4.jpg GRAPHIC 59048
11 jazz-20251231_g5.jpg GRAPHIC 62690
  Complete submission text file 0001628280-26-027205.txt   2547244

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20251231.xsd EX-101.SCH 2532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20251231_lab.xml EX-101.LAB 138291
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20251231_pre.xml EX-101.PRE 74838
25 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20251231_htm.xml XML 11015
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33500 | Film No.: 26893762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)